Management of germ cell and stromal tumors of the ovary.
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002822:Choriocarcinoma / Q000628:therapy; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004407:Dysgerminoma / Q000628:therapy; D005260:Female; D006106:Granulosa Cell Tumor / Q000628:therapy; D006801:Humans; D007984:Leydig Cell Tumor / Q000628:therapy; D008649:Mesonephroma / Q000628:therapy; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000473:pathology / Q000628:therapy*; D011247:Pregnancy; D012707:Sertoli Cell Tumor / Q000628:therapy; D013724:Teratoma / Q000628:therapy; D013798:Thecoma / Q000628:therapy; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide